Spero Therapeutics, Inc. (SPRO)
NASDAQ: SPRO · Real-Time Price · USD
2.740
-0.060 (-2.14%)
At close: Apr 24, 2026, 4:00 PM EDT
2.710
-0.030 (-1.09%)
After-hours: Apr 24, 2026, 4:31 PM EDT
Spero Therapeutics Market Cap
Spero Therapeutics has a market cap or net worth of $158.62 million as of April 24, 2026. Its market cap has increased by 380.67% in one year.
Market Cap
158.62M
Enterprise Value
121.25M
1-Year Change
380.67%
Ranking
Category
Stock Price
$2.74
Market Cap Chart
Since November 2, 2017, Spero Therapeutics's market cap has increased from $154.10M to $158.62M, an increase of 2.93%. That is a compound annual growth rate of 0.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2026 | 158.60M | 20.79% |
| Dec 31, 2025 | 131.30M | 133.63% |
| Dec 31, 2024 | 56.20M | -27.86% |
| Dec 29, 2023 | 77.90M | -13.06% |
| Dec 30, 2022 | 89.60M | -82.69% |
| Dec 31, 2021 | 517.50M | -1.84% |
| Dec 31, 2020 | 527.20M | 186.68% |
| Dec 31, 2019 | 183.90M | 64.34% |
| Dec 31, 2018 | 111.90M | -33.71% |
| Dec 29, 2017 | 168.80M | 9.54% |
| Nov 2, 2017 | 154.10M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Protalix BioTherapeutics | 177.26M |
| Jyong Biotech | 174.56M |
| TuHURA Biosciences | 170.39M |
| KALA BIO | 164.06M |
| Molecular Partners AG | 163.95M |
| Galectin Therapeutics | 161.28M |
| Tenaya Therapeutics | 159.73M |
| Fate Therapeutics | 159.28M |